ICVTS Click here for other ICVTS advertising opportunities
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Interact CardioVasc Thorac Surg 2009;8:439-441. doi:10.1510/icvts.2008.193177
© 2009 European Association of Cardio-Thoracic Surgery

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Robert Kramer
Louis Russo
John H. Braxton
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kramer, R.
Right arrow Articles by Braxton, J. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kramer, R.
Right arrow Articles by Braxton, J. H.
Related Collections
Right arrowRelated Article

Proposal for bail-out procedures - Cardiac general

Heparin-induced thrombocytopenia with thrombosis syndrome managed with plasmapheresis{star}

Robert Kramera,*, Payson Oberg-Higginsb, Louis Russoa and John H. Braxtona

a Division of Cardiothoracic Surgery, Maine Medical Center, 22 Bramhall St., Portland, ME 04102, USA
b Division of Nephrology, Maine Medical Center, 22 Bramhall St., Portland, ME 04102, USA

*Corresponding author. Tel.: +1 207-662-2414; fax: +1 207-662-6038.

E-mail address: kramer{at}mmc.org (R. Kramer).

Heparin-induced thrombocytopenia with thrombosis syndrome is an antibody-mediated disorder that has a high mortality in cardiac surgical patients in spite of early diagnosis and management with direct thrombin inhibitors. Plasmapheresis, an extracorporeal technique that has been designed for the removal of large molecular weight substances from the plasma, can remove the offending antibodies from these desperately ill patients. We describe a case of a postoperative cardiac surgery patient with heparin-induced thrombocytopenia with thrombosis syndrome and multi-system failure who was dependent upon a left ventricular assist device. He was treated successfully with plasmapheresis with recovery of his platelet count from 25,000/µl to over 200,000/µl, along with multi-organ recovery. This patient survived because of plasmapheresis. Removing the antibodies to the heparin-platelet factor four complex with plasmapheresis is an effective strategy to treat these patients. We believe that the use of plasmapheresis as a bail-out procedure in these often desperately ill post-operative cardiac surgical patients who have heparin-induced thrombocytopenia with thrombosis syndrome could be lifesaving.

Key Words: Thrombosis; Blood platelets; Immunochemistry; Hematology


Related Article

eComment: Plasmapheresis for near-fatal heparin-induced thrombocytopenia
Karsten Knobloch, Marc Busche, and Kay H. Busch
Interactive CardioVascular and Thoracic Surgery 2009 8: 441. [Full Text] [PDF]



This article has been cited by other articles:


Home page
ICVTSHome page
K. Knobloch, M. Busche, and K. H. Busch
eComment: Plasmapheresis for near-fatal heparin-induced thrombocytopenia
Interactive CardioVascular and Thoracic Surgery, April 1, 2009; 8(4): 441 - 441.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2009 European Association for Cardio-thoracic Surgery